Kyle Dunton - Concepedia

Author

Kyle Dunton

Also Known As

Dunton K, K Dunton, K. Dunton, Kyle Dunton, Kyle J. Dunton, Kyle John Dunton

Publications

178

Citations

H-Index

Concepts

All Affiliations

Kyle Dunton is an author at Daiichi Sankyo (United States) specializing in clinical trials, breast cancer, and cancer therapeutics.

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	18
2	Medicine	1	1	18
3	Cancer Therapeutics	1	1	18
4	Clinical Trials	1	1	18
5	Breast Cancer	1	1	18

Kyle Dunton

Publications

123

Citations

H-Index

Page 1

	Year	Citations
Patient-reported outcomes and hospitalization data in patients with HER2-positive metastatic breast cancer receiving trastuzumab deruxtecan or trastuzumab emtansine in the phase III DESTINY-Breast03 study Giuseppe Curigliano, Kyle Dunton, Mats Rosenlund, Annals of Oncology	2023	41
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial Tanja Fehm, Francesco Cottone, Kyle Dunton, The Lancet Oncology	2024	35
Prevalence and Patient Outcomes of Adult Primary Hypercholesterolemia and Dyslipidemia in the UK: Longitudinal Retrospective Study Using a Primary Care Dataset from 2009 to 2019 Aikaterini Bilitou, John Were, Archie Farrer, SHILAP Revista de lepidopterología	2022	29
217O Patient-reported outcomes (PROs) from DESTINY-Breast04, a randomized phase III study of trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC) in patients (pts) with HER2-low metastatic breast cancer (MBC) Naoto T. Ueno, William Jacot, Toshinari Yamashita, Annals of Oncology Patient-reported OutcomesBreast OncologyMedicineCancer ManagementClinical Trials	2022	18

Page 1